353 Evaluation of immunization status in psoriasis patients prior to initiation of immunosuppressive therapy- A multidisciplinary approach

Immunosuppressive medications are a mainstay of psoriasis treatment. As these increase the risk infection, Pre-Immunosuppression Clinic at Beth Israel Deaconess Medical Center (BIDMC) was created to screen for infectious diseases and evaluate vaccination status patients prior starting immunosuppressive therapies. Of 78 (mean age= 50, SD= 14, Males= 54% Females= 46%) who were prescribed through Department Dermatology BIDMC from April 2021-Dec 2021, 48 (62%) referred Clinic. those referred, 39 (81%) followed up. Additional indicated 100% all received least one vaccine. The PPSV23 (n= 33, 85%), PCV13 31, 80%), Recombinant, Adjuvanted Zoster Vaccines 21, 54%) most frequently ordered. 23 (59%) had additional screening labs ordered based on history individual risk. Most that led referrals include risankizumab 27, 56%), secukinumab ustekinumab 6, 12%). Mean age vaccinations 50 years (SD= 14), mean number days between date referral placed clinic visit 16 11). high percentage qualified after evaluation in demonstrates need systematic, multidisciplinary effort improve rates initiating